MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Urology and Nephrology

• Publication date

  2018-03-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11255-018-1841-xPMID 29549624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis

  2018cited by this paper
• Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients

  2017cited by this paper
• Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma.

  2017cited by this paper
• MicroRNA-15a Inhibits Proliferation and Induces Apoptosis in CNE1 Nasopharyngeal Carcinoma Cells

  2016cited by this paper
• Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and −186 expression: Novel mechanism of VEGF modulation in prostate cancer

  2016cited by this paper
• Clinical Usage of Different Guidelines in Routine Management, Therapy and Follow-Up of Patients with Renal Cell Cancer in Germany

  2016cited by this paper
• Implications of dynamic changes in miR-192 expression in ischemic acute kidney injury

  2016cited by this paper
• European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma

  2016cited by this paper
• Urinary microRNAs as a new class of noninvasive biomarkers in oncology, nephrology, and cardiology.

  2015cited by this paper
• Simplification of the Fuhrman grading system for renal cell carcinoma.

  2015cited by this paper
• Diminished expression of MiR-15a is an independent prognostic marker for breast cancer cases.

  2015cited by this paper
• Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients

  2014cited by this paper
• Hippo Signaling Mediates Proliferation, Invasiveness, and Metastatic Potential of Clear Cell Renal Cell Carcinoma

  2014cited by this paper
• Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma

  2014cited by this paper
• miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression

  2014cited by this paper
• MicroRNA expression signatures of stage, grade, and progression in clear cell RCC

  2014cited by this paper
• Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma.

  2014cited by this paper
• Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention

  2013cited by this paper
• Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma

  2012cited by this paper
• MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples.

  2012cited by this paper
• Protein kinase C α regulates nuclear pri-microRNA 15a release as part of endothelin signaling.

  2011cited by this paper
• Accurate molecular classification of kidney cancer subtypes using microRNA signature.

  2011cited by this paper
• Incidence of benign pathologic lesions at nephrectomy for renal masses presumed to be stage I renal cell carcinoma in Japanese patients: Impact of sex, age, and tumor size.

  2011cited by this paper
• The emerging role of nuclear factor kappa B in renal cell carcinoma.

  2011cited by this paper
• MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation.

  2010cited by this paper
• MicroRNAs modulate the noncanonical NF-κB pathway by regulating IKKα expression during macrophage differentiation

  2010cited by this paper
• The current role of percutaneous needle biopsies of renal tumours.

  2009cited by this paper
• A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.

  2009cited by this paper
• Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.

  2009cited by this paper
• Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.

  2008cited by this paper
• Endothelin-1 Induces NF-κB via Two Independent Pathways in Human Renal Tubular Epithelial Cells

  2007cited by this paper
• Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass.

  2005cited by this paper

• Machine learning-assisted radiogenomic analysis for miR-15a expression prediction in renal cell carcinoma

  2025cites this paper
• Evaluation of Urinary miRNA in Renal Cell Carcinoma: A Systematic Review

  2025cites this paper
• Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer.

  2025cites this paper
• Liquid biopsy: an emerging field with new opportunities for cancer diagnosis and prognosis

  2025cites this paper
• Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers

  2025influential citation
• Urinary miRNAs: Technical Updates.

  2024cites this paper
• Liquid Biopsy: A New Avenue for the Diagnosis of Kidney Disease: Diabetic Kidney Disease, Renal Cancer, and IgA Nephropathy

  2024cites this paper
• Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles

  2024influential citation
• Liquid biopsy in cancer: current status, challenges and future prospects

  2024cites this paper
• Differentiation of solid and friable tumour thrombus in patients with renal cell carcinoma: the role of MRI apparent diffusion coefficient.

  2024cites this paper
• Liquid biopsy for renal cell carcinoma.

  2024cites this paper
• Evaluating the Urinary Exosome microRNA Profile of von Hippel Lindau Syndrome Patients with Clear Cell Renal Cell Carcinoma

  2024cites this paper
• Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application

  2023cites this paper
• Role of microRNAs in renal cancer diagnostics

  2023cites this paper
• Urinary miRNAs Predict Metastasis in Patients With Clinically Localized Clear Cell Renal Cell Carcinoma Treated With Nephrectomy.

  2023cites this paper
• Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer

  2023cites this paper
• Regulatory role of circular RNAs in oral squamous cell carcinoma.

  2023cites this paper
• Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review

  2023cites this paper
• The performance and limitations of PCA3, TMPRSS2:ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics.

  2023cites this paper
• A review on the role of long non-coding RNA and microRNA network in clear cell renal cell carcinoma and its tumor microenvironment

  2023cites this paper
• Multifunctional role of Nobiletin in cancer chemoprevention.

  2022cites this paper
• The role of Exosomal miRNAs in cancer

  2022cites this paper
• High efficiency capture of biomarker miRNA15a for noninvasive diagnosis of malignant kidney tumors.

  2022cites this paper
• Canadian Urological Association guideline: Management of small renal masses - Full-text.

  2022cites this paper
• LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma

  2022cites this paper
• Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma

  2022cites this paper
• Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer

  2022cites this paper
• Role of DNA Methyltransferases (DNMTs) in metastasis.

  2022cites this paper
• Frontiers of Ferroptosis in Cancer Treatment.

  2022cites this paper
• Diagnostic Strategies for Urologic Cancer Using Expression Analysis of Various Oncogenic Surveillance Molecules—From Non-Coding Small RNAs to Cancer-Specific Proteins

  2022cites this paper
• MicroRNAs as Potential Biomarkers and Therapeutic Targets in Renal Cell Carcinoma

  2022cites this paper
• Epidemiology and Prevention of Renal Cell Carcinoma

  2022cites this paper
• The Role of miRNA in the Management of Localized and Advanced Renal Masses, a Narrative Review of the Literature

  2022cites this paper
• Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature.

  2021cites this paper
• CMAR_A_330881 7663..7675

  2021cites this paper
• Exosomal microRNA‐15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis

  2021cites this paper
• A 25-year perspective on evaluation and understanding of biomarkers in urologic cancers.

  2021cites this paper
• Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests

  2021influential citation
• MicroRNAs in Body Fluids: A More Promising Biomarker for Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma

  2021cites this paper
• Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose

  2021influential citation
• Circulating Tumor Cell Detection Methods in Renal Cell Carcinoma: A Systematic Review.

  2021cites this paper
• Urinary microRNA and mRNA in Tumors.

  2021cites this paper
• Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma

  2020cites this paper
• Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies

  2020cites this paper
• RNA Interference and CRISPR Technologies: Technical Advances and New Therapeutic Opportunities

  2020cites this paper
• Urinary MicroRNAs as Emerging Class of Noninvasive Biomarkers.

  2020cites this paper
• Expressions of microRNA-29a and microRNA-34a in pleomorphic adenomas of salivary glands.

  2020cites this paper
• Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma

  2020cites this paper
• Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs

  2020cites this paper
• Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer

  2020cites this paper
• MicroRNAs as markers to monitor endothelin‐1 signalling and potential treatment in renal disease: Carcinoma − proteinuric damage − toxicity

  2019cites this paper
• Focusing on the brighter side of Sevoflurane: Realizing true potential of an anesthetic agent as a regulator of cell signaling pathways and microRNAs in different cancers.

  2019cites this paper
• Renal Cell Carcinoma Biomarkers in Proximal Fluids

  2019cites this paper
• MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma

  2019cites this paper
• Urinary microRNA in kidney disease: utility and roles.

  2019cites this paper
• Beyond the 3′UTR binding–microRNA-induced protein truncation via DNA binding

  2018cites this paper
• Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives

  2018cites this paper
• World Journal of Clinical Oncology

  year unknowninfluential citation